doi:10.1007/s12250-016-3808-3

[1]
Dezhi Li, Jie Liu, Li Zhang, Tianshu Xu, Junheng Chen, Liping Wang, Qi Zhao, 2015: N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies, Virologica Sinica, 30, 449-456. doi: 10.1007/s12250-015-3664-6
[2]
Xue-qing Chen, Chang Liu, Xiao-hong Kong, 2011: The Role of HIV Replicative Fitness in Perinatal Transmission of HIV, Virologica Sinica, 26, 147-155. doi: 10.1007/s12250-011-3180-2
[3]
Tielong Chen, Yilan Hu, Quanquan Ding, Jing Yu, Fubing Wang, Fengling Luo, Xiao-Lian Zhang, 2015: Serum ficolin-2 concentrations are significantly changed in patients with hepatitis B virus infection and liver diseases, Virologica Sinica, 30, 249-260. doi: 10.1007/s12250-015-3605-4
[4]
Jian-hui NIE, Chun-tao ZHANG, Hui-hui CHONG, Xue-ling WU, Chun-yu LIU, Yu WU, Chen-yan ZHAO, Lin-qi ZHANG, You-chun WANG, 2008: Comparison of the Immunogenicities of HIV-1 Mutants Based on Structural Modification of env, Virologica Sinica, 23, 233-246. doi: 10.1007/s12250-008-2949-4
[5]
王福祥, 孙永涛, 潘艳, 2005: SDF-1 Gene Modulates Immune Responses Induced by HIV-1 Nucleic Acid Vaccine, Virologica Sinica, 20, 243-246.
[6]
Chang Li, Wei Jin, Tao Du, Biao Wu, Yalan Liu, Robin J Shattock, Qinxue Hu, 2014: Binding of HIV-1 virions to α₄β₇ expressing cells and impact of antagonizing α₄β₇ on HIV-1 infection of primary CD4⁺ T cells, Virologica Sinica, 29, 381-392. doi: 10.1007/s12250-014-3525-8
[7]
Zheng Wang, Tian-yi Li, Jing-yun Li, Li-li Chen, Yong-jian Liu, Han-ping Li, Zuo-yi Bao, Xiao-lin Wang, Dao-min Zhuang, Si-yang Liu, Lin Li, 2012: Similar Neutralizing Activity in the HIV-1 Infected Long Term Non-progressors(LTNPs) and Typical Progressors(TPs)^*, Virologica Sinica, 27, 165-171. doi: 10.1007/s12250-012-3239-8
[8]
王福祥, 潘艳, 孙永涛, 2005: Chemokine Genes Modulate Immune Responses Induced by HIV-1 Envelope Protein Gene Vaccine, Virologica Sinica, 20, 578-581.
[9]
王云华, 王睿睿, 杨柳萌, 李健峰, 徐维明, 郑永唐, 2006: Expression and Purification of HIV-1 Protease and the Establishment of a Method for Protease Inhibitor Screening, Virologica Sinica, 21, 126-130.
[10]
Ling Su, Xia Zhou, Dan Yuan, Hong Yang, Dongbing Wei, Guangmin Qin, Shu Liang, 2014: Prevalence and patterns of drug-resistance mutations among HIV-1 patients infected with CRF07_BC strains in Sichuan province, China, Virologica Sinica, 29, 237-241. doi: 10.1007/s12250-014-3487-x
[11]
Zhipin Liang, Zhiyuan Guo, Xin Wang, Xiaohong Kong, Chang Liu, 2012: Two Retroviruses Packaged in One Cell Line can Combined Inhibit the Replication of HIV-1 in TZM-bl Cells ^*, Virologica Sinica, 27, 339-344. doi: 10.1007/s12250-012-3263-8
[12]
许四宏, 宋爱京, 李秀华, 王佑春*, 2006: Studies on National Reference of HIV-1 P24 Antigen, Virologica Sinica, 21, 102-105.
[13]
王福祥, 孙永涛*, 王临旭, 王久平, 王平忠, 白雪帆, 黄长形, 2004: Construction and Expression of HIV-1 Env Eukaryotic Expression Vector, Virologica Sinica, 19, 70-72.
[14]
Jian Gong, Xiao-qiong Wang, Xiao Tong, Xi-hui Shen, Rong-ge Yang, 2011: Emerging Trends of Drug-Resistant HIV-1 among Drug-Treated Patients in Former Blood Donors in Hubei, China: a Three-Year Surveillance from 2004 to 2006, Virologica Sinica, 26, 386-392. doi: 10.1007/s12250-011-3210-0
[15]
Tingting Li, Feng Qian, Ting Yuan, Weilu Xu, Li Zhu, Jinlong Huang, Haiyan Wang, Yueping Zhu, Yinling Wang, Xiaohong Li, Saihong Gu, Zhuqing Tan, Hui Chen, Xiangrong Luo, Wei Zhu, Wenjuan Lu, Ping Xu, Ming Li, Yuying Chen, Yong Gao, Rongge Yang, Chuanwu Zhu, Binlian Sun, 2017: Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China, Virologica Sinica, 32, 271-279. doi: 10.1007/s12250-017-4002-y
[16]
江文正, 金宁一*, 李子健, 张立树, 张洪勇, 2004: Co-inoculating DNA Vaccine of HIV-1 gag-gp120 and IL-2, Virologica Sinica, 19, 10-13.
[17]
刘连兴, 郝彦玲, 袁国亮, 许斌, 傅晶晶, 刘勇, 邵一鸣, , 2006: Expression and purification of HIV Integrase in E. col i and Application in HIV Diagnosis, Virologica Sinica, 21, 413-416.
[18]
Zuopeng Zhang, Sen Yuan, Shuting Xu, Deyin Guo, Lang Chen, Wei Hou, Min Wang, 2021: Suppression of HIV-1 Integration by Targeting HIV-1 Integrase for Degradation with A Chimeric Ubiquitin Ligase, Virologica Sinica, 36, 424-437. doi: 10.1007/s12250-020-00311-5
[19]
邓刚, 苏旸, 母俊杰, 李悦, 乔文涛, 耿运琪, 陈启民*, 2006: JDV Tat has Strong Transactivate Ability Because of its RNA Binding Domain, Virologica Sinica, 21, 142-147.
[20]
Xiaolong Tian, Binbin Hong, Xiaoyi Zhu, Desheng Kong, Yumei Wen, Yanling Wu, Liying Ma, Tianlei Ying, 2022: Characterization of human IgM and IgG repertoires in individuals with chronic HIV-1 infection, Virologica Sinica, 37, 370-379. doi: 10.1016/j.virs.2022.02.010